Logo print RMMS Rakoczy Molino Mazzochi Siwik LLP
  • About
  • Services
  • Profiles
  • News
  • Contact
  • X
  • News

News

U.S. Court Of Appeals For The Federal Circuit Affirms RMMS's Victory Involving Generic Ibandronate Products

04/11/2014

RMMS Secures Judgment Of Non-Infringement After A Trial Involving Generic Trizivir® (Abacavir Sulfate; Lamivudine; Zidovudine) Tablets

12/17/2013

RMMS Secures Judgment Of Patent Invalidity After A Trial Involving Gatifloxacin Ocular Formulation and Method

08/09/2013

Federal Circuit Affirms Judgment Of Non-Infringement Involving Generic Mometasone Furoate Nasal Spray

06/10/2013

RMMS Secures Judgment Of Patent Invalidity And Non-Infringement After A Trial Involving Budesonide Inhalation Suspension

04/01/2013

RMMS Defeats Motion for Preliminary Injunction Involving Generic Tiagabine Hydrochloride Products

12/20/2012

RMMS LLP recognized as one of the top Hatch-Waxman litigation firms in the country by LMG Life Sciences

06/16/2012

RMMS Secures Judgment Of Non-Infringement After A Trial Involving Generic Mometasone Furoate Nasal Spray

06/15/2012

RMMS Defeats Motion for Preliminary Injunction Involving Generic Ibandronate Products

03/14/2012

RMMS Secures Summary Judgment of Non-Infringement Involving Generic Guaifenesin Extended-Release Tablets, 600 mg

01/11/2012
Newer 1 2 3 4 5 6 Older

Services

  • Litigation
    • Small Molecules and Biologics
    • Regulatory Litigation
    • Representative Matters
    • Litigation Highlights
  • Patent Counseling
  • Regulatory Counseling
    • About
    • Services
    • Profiles
    • News
    • Contact
    • Disclaimers
    • Copyright © 2021 Rakoczy Molino Mazzochi Siwik LLP